all-trans-retinoid acid

DRUG2 trials

Sponsors

University of Ulm, First Affiliated Hospital of Suzhou Medical College

Conditions

Immune Thrombocytopenic PurpuraLeukemia, Myeloid, Acute

Phase 2

Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)

CompletedNCT00143975

University of UlmLeukemia, Myeloid, Acute

Start: 2004-06-30End: 2009-06-30Updated: 2010-08-12

Unknown Phase

Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia

CompletedNCT01668615

First Affiliated Hospital of Suzhou Medical CollegeImmune Thrombocytopenic Purpura

Start: 2011-01-31End: 2012-08-31Updated: 2012-10-23